biologic or biosimilar in ibd. it doesn’t matter which.
Published 1 year ago • 323 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
2:28
what are biologic and biosimilar drugs?
-
5:34
ibd: switching from a biologic to a biosimilar
-
38:39
considerations in use of biosimilars for gastrointestinal disorders
-
1:47
understanding biosimilars - for ibd patients
-
39:51
why ibd patients should know about biosimilars
-
1:33:50
biologic and biosimilar medications for inflammatory bowel disease (ibd)
-
19:14
04 why patients should know about biosimilars
-
1:22:22
making the switch from biologics to biosimilars in ibd: knowledge over skepticism
-
34:05
biosimilars in ibd treatment: expert panel discussion | ibd pro
-
4:04
biosimilars and inflammatory bowel disease
-
49:21
biologics in ibd: can we afford to use them?
-
18:23
biosimilars for ibd: to start, switch, or stay away?
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
23:19
navigating insurance as a crohn's or colitis patient: what is a biosimilar?
-
8:17
biologics and inflammatory bowel disease
-
11:40
debate: biosimilar therapies - caution, more studies are needed
-
21:14
when and how to use immunomodulators and biologics in ibd
-
16:48
biosimilars in ibd: where do we stand today?
-
33:34
optimizing the efficacy of immunomodulators and biologics in pediatric ibd